Changes

Jump to: navigation, search

Ureteral Stent

36 bytes added, 07:10, 7 January 2010
/* Market Data */
The number of ureteral stents used in patients with stones 2 cm or less treated with ESWL is significant in spite of the lack scientific evidence in support of this practice. Of 1,029 urologists returning surveys, for patients with renal pelvic stones 10, 15 or 20 rnm treated with ESWL, routine stent placement was preferred by 25.3%, 57.1 % and 87.1 %, respectively. Urologists recommend using ureteroscopy rather than ESWL for distal ureteral calculi 5-1 0 mm.
===Market Data=Analysis==
* We determined market data to have an idea about the market potential for ureteral stents.
* This data is for women in US in different age groups and having different level of severity.
* Among all, 9% reported slight UI, 15% reported moderate UI, 18% reported severe UI, and 58% reported no UI.
<BR>
===Methodology===
 
===Prevalence rate===
{|border="2" cellspacing="0" cellpadding="4" width="100%"
|align = "center" colspan = "2"|'''Prevalence of Urinary Incontinence in US Women'''
[http://archinte.ama-assn.org/cgi/content/full/165/5/537 Source]
'''===Urinary incontinence severity among different age groups in US women:'''<BR>===
[[Image:urinary incontinence severity.jpg|center|500px|thumb|[http://archinte.ama-assn.org/cgi/content/full/165/5/537 Source]]]
'''===Market potential for ureteral stents:'''stent===
{|border="2" cellspacing="0" cellpadding="4" width="100%"
* Ureteral stent market is growing at a CAGR of 1.47%
<Br>
'''===Ureteral stent market forecast in US (female)'''===
[[Image:stent market forecast.jpg|center|600px]]
505
edits